Maintenance of ovarian function and risk of premature menopause related to cancer treatment.
about
Xenobiotic effects on ovarian preantral folliclesPremature menopause or early menopause: long-term health consequencesHow do chemotherapeutic agents damage the ovary?Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complicationsOvarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor StudyPathogenesis and causes of premature ovarian failure: an update.Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapyFemale long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first reportScreening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.Fertility preservation in reproductive-age women facing gonadotoxic treatments.Reproductive late effects in female survivors of childhood cancer.Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.Reproductive outcomes for survivors of childhood cancer.Accelerated ovarian aging in mice by treatment of busulfan and cyclophosphamide.Premature menopause.Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects.Female survivors of childhood cancer: preterm birth and low birth weight among their children.Radiation dose and breast cancer risk in the childhood cancer survivor study.Contraception for cancer survivors.Current approach to fertility preservation by embryo cryopreservationExploring the concept of uncertain fertility, reproduction and motherhood after cancer in young adult women.Estrogen therapy in gynecological cancer survivors.Fertility issues in cancer survivorship.An approach to fertility preservation in prepubertal and postpubertal females: a critical review of current literature.Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study.[Hodgkin's lymphoma during childhood and adolescence: parenthood rates not lower after radiation treatment outside the pelvis].Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty.Fertility and sexual function in female Hodgkin lymphoma survivors of reproductive age.Gonadotropin-releasing hormone analog treatment for the prevention of treatment-related ovarian failure and infertility in women of reproductive age with Hodgkin lymphoma.Premature Ovarian Insufficiency - an update on recent advances in understanding and management.Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.Ovarian tissue cryopreservation and transplantation in patients with cancer.Effects of cyclophosphamide administration on the in vitro fertilization of mice.
P2860
Q24634884-BB386258-D136-4909-BF0F-B96DEFBB370DQ28257628-F70D7539-7E9B-4680-BAFF-EFE4F2B921F5Q28267696-E4C19218-385B-4ED7-9E00-60A834B6D624Q28383280-EF521D18-EA32-4482-9C0C-0AB6FC09F0A9Q33429787-8BA6C266-5F75-43F1-AAAB-7C395848581CQ33764453-A9753717-E3C1-48E6-AE84-FE196B2C3430Q34954883-424436EE-26E5-4AD4-951C-F2550299FD3FQ35671371-D0A488C6-638D-41C5-96E0-9D4A32C3D137Q35782720-6762B906-AAB4-448B-AAD3-57E8609EA0E1Q35815806-E6C64F5E-75F3-41A0-88A0-91F8593C9892Q35934317-BDA2806A-C526-40F7-80C6-C3EF6D65A166Q35961728-1F466D13-AB62-4231-BEBF-9BE75D303177Q36384739-83D6E9B2-B27E-48B2-809D-7EE2938DE982Q36509306-3E5D6C27-3137-4546-B59A-AD12CFC17472Q36763323-0B74E793-36AD-4FE4-ADF4-281885840D33Q36789707-898EAC0D-3A32-4EDF-ABAF-6C827D75A5FBQ37231338-C0F56E93-E4AB-454C-9F11-3DDFE778C297Q37313765-DE80A8E7-0440-49DB-B4A1-6C45B12A731FQ37324982-FA64FC37-44F7-47FE-941C-01D631C3F62CQ37390053-6CBB4B0F-2B8D-44DD-8F3E-83CD2EE0CD45Q37676012-D095D763-B373-4FDC-95A6-E79CB125CF1DQ37874688-A628644C-AFCA-41B9-B618-3D8DD6537A06Q38129452-22F17735-1320-4A25-95E3-28904C5D0745Q38194105-56CDAD2E-413A-421A-9AF6-A47B858F5854Q38367635-3BA9FC19-87A2-4C11-BAD6-414F81FA2C10Q40310163-C6D76C0A-0DF5-4CA8-AA6F-6634BA5C6C98Q41222095-ED64EB7A-BFAA-4730-AA6E-BFE89C4F6F60Q43665560-398960A9-5271-4CFD-A597-41A07CCDA433Q45898041-BC17E559-E541-4DD4-8872-9E436209CDCFQ46615383-0B356B02-4B44-448F-8856-125681EC83DCQ47101603-2AB5C5E4-0835-410C-ACBD-F061CADD994CQ51662152-AB0BD29A-88F1-4EC7-941F-F08BCB69E9FEQ55689271-F760A04A-2E00-4B62-8DD1-F54908F3E5EBQ55714765-8F56A022-ED84-4E92-8CDF-4BD643C68834
P2860
Maintenance of ovarian function and risk of premature menopause related to cancer treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Maintenance of ovarian functio ...... e related to cancer treatment.
@ast
Maintenance of ovarian functio ...... e related to cancer treatment.
@en
type
label
Maintenance of ovarian functio ...... e related to cancer treatment.
@ast
Maintenance of ovarian functio ...... e related to cancer treatment.
@en
prefLabel
Maintenance of ovarian functio ...... e related to cancer treatment.
@ast
Maintenance of ovarian functio ...... e related to cancer treatment.
@en
P356
P1476
Maintenance of ovarian functio ...... e related to cancer treatment.
@en
P2093
Charles Sklar
P356
10.1093/JNCIMONOGRAPHS/LGI018
P577
2005-01-01T00:00:00Z